Extreme Networks buy BiotechBee
Summary
This prediction ended on 01.10.23 with a price of €22.81. The prediction for Extreme Networks disappointed with a performance of -24.34%. BiotechBee has 60% into this predictionExtreme Networks (EXTR) is a publicly listed company that provides comprehensive software-driven networking solutions for enterprise customers. The company designs, develops, and sells networking equipment, software, and services to create seamless experiences for its customers. It offers various products such as switches, routers, and wireless access points that are used by businesses and organizations to establish connectivity and network infrastructure. Extreme Networks focuses mainly on technology, education, healthcare, and hospitality markets, serving customers across the globe through its network of distributors, resellers, and partners.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Extreme Networks | 3.905% | 3.905% | -43.647% |
iShares Core DAX® | -0.168% | 4.802% | 17.488% |
iShares Nasdaq 100 | 2.946% | 3.520% | 23.619% |
iShares Nikkei 225® | 1.319% | 6.746% | 12.949% |
iShares S&P 500 | 2.044% | 3.551% | 23.055% |
According to BiotechBee what are the pros and cons of Extreme Networks for the foreseeable future?
Pros
Cons
Comments by BiotechBee for this prediction
In the thread Extreme Networks diskutieren
In the thread Trading Extreme Networks